Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCFinancial_Report.xls
10-Q - UTAH MEDICAL PRODUCTS, INC. 10Q 2011-09-30 - UTAH MEDICAL PRODUCTS INCutahmedical10q20110930.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR3.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR6.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR7.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR9.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR8.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR5.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR1.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR2.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR14.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR13.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR11.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR12.htm
XML - IDEA: XBRL DOCUMENT - UTAH MEDICAL PRODUCTS INCR10.htm
EX-32.2 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - UTAH MEDICAL PRODUCTS INCutahmedical10qexh322.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - UTAH MEDICAL PRODUCTS INCutahmedical10qexh311.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - UTAH MEDICAL PRODUCTS INCutahmedical10qexh312.htm
EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - UTAH MEDICAL PRODUCTS INCutahmedical10qexh321.htm
v2.3.0.15
UTAH MEDICAL PRODUCTS, INC. AND SUBSIDIARIES CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (USD $)
In Thousands
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Net income$ 5,556$ 4,505
Depreciation536416
Amortization1,42433
(Gain) loss on investments(6)(39)
Provision for (recovery of) losses on accounts receivable104
Deferred income taxes(374) 
(Gain) loss on disposal of assets 0
Stock-based compensation expense7364
Accounts receivable - trade287303
Accrued interest and other receivables(26)(45)
Inventories(579)122
Prepaid expenses and other current assets16348
Accounts payable(439)21
Accrued expenses95555
Deferred revenue(52) 
Other liability330 
Total adjustments2,303982
Net cash provided by operating activities7,8595,487
Capital expenditures for property and equipment(196)(1,418)
Capital expenditures for intangible assets(8)(2)
Purchases of investments(500)(1,200)
Proceeds from sale of investments15,1552,639
Net cash paid in acquisition(41,084) 
Net cash provided by (used in) investing activities(26,633)19
Proceeds from issuance of common stock - options442380
Common stock purchased and retired (439)
Tax benefit attributable to exercise of stock options3030
Proceeds from notes payable26,934 
Repayments of note payable(3,682)(302)
Payment of dividends(1,705)(1,707)
Net cash provided by (used in) financing activities22,019(2,037)
Effect of exchange rate changes on cash(23)(28)
NET INCREASE (DECREASE) IN CASH3,2223,441
CASH AT BEGINNING OF PERIOD3,818410
CASH AT END OF PERIOD7,0403,851
Cash paid during the period for income taxes2,0152,055
Cash paid during the period for interest$ 636$ 19